Trial intelligence / Profile preview

MUSE for erectile function after nerve-sparing radical prostatectomy

2005-003971-19Phase 4Terminated

Sponsor
Viatris
Start
Nov 2005
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of Vasostenoon in erectile dysfunction (ED) (2 arms), sponsored by Viatris. Primary endpoint: Erectile function by IIEF questionnaire. Started Nov 2005; status: terminated.

02

Drugs

Vasostenoon
03

Conditions

erectile dysfunction (ED)

Beyond the preview

Go deeper on 2005-003971-19.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-003971-19.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call